Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.88 USD | -0.60% | +0.10% | +24.22% |
01/05 | Encompass Health Insider Sold Shares Worth $3,745,152, According to a Recent SEC Filing | MT |
29/04 | UBS Adjusts Encompass Health Price Target to $96 From $88, Maintains Buy Rating | MT |
Evolution of the average Target Price on Encompass Health Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Encompass Health Corporation
UBS | |
Mizuho Securities | |
Barclays | |
Deutsche Bank Securities | |
RBC Capital Markets | |
Credit Suisse | |
Truist Securities | |
Stephens Inc. | |
Raymond James | |
BofA Securities | |
BMO Capital | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- EHC Stock
- Consensus Encompass Health Corporation